Indegene IPO: Issue booked 55% on Day 1, so far. NII portion fully subscribed; check GMP, subscription status, key dates
₹30 per equity share. The qualified institutional buyers (QIBs) portion is yet to be booked. At 12:51 IST, the Indegene IPO subscription status is 55%, as per BSE data.
The NII portion has been subscribed 1.01 times, followed by retail, which has been booked 66%, so far. The employee portion has been subscribed 69%. Also Read: Indegene IPO opens: GMP, subscription status, review, price, date, lot size, other details.
Apply or not? Indegene IPO, which has opened for subscription today (Monday, May 6), will close on Wednesday, May 8. The price band has been set in the range of ₹430 to ₹452 per equity share of the face value of ₹2. Indegene IPO raised ₹548.77 crore from 36 anchor investors at the upper price band of ₹452 per equity share on Friday, May 3.
In the public offering, it has set aside 15% for NII, a maximum of 50% for QIB, and 35% for retail investors. For the life sciences sector, Indegene Limited offers digital services. They provide help for complaints handling, pharmacovigilance, clinical trial management, regulatory submissions, medication development, and sales and marketing.
Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical Solutions, Enterprise Clinical Solutions, and consulting services are some of the areas into which the company's services may be separated. Also Read: Indegene IPO: Mumbai-based company raises ₹548.77 crore from anchor investors ahead of IPO Indegene IPO has received bids for 1,60,06,155 shares against 2,88,66,677 shares on offer, at 12:51 IST, according to data from the BSE. The retail investors' segment received bids for 94,78,854 shares against 1,44,60,759 shares on offer for this segment.
Read more on livemint.com
